中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel

文献类型:期刊论文

作者Yu, Haijun1; Xu, Zhiai2; Chen, Xianzhi1; Xu, Leilei3; Yin, Qi1; Zhang, Zhiwen1; Li, Yaping1
刊名MACROMOLECULAR BIOSCIENCE
出版日期2014-01
卷号14期号:1页码:100-109
关键词lung cancer micelleplexes multidrug resistance Paclitaxel pH-responsive siRNA
ISSN号1616-5187
DOI10.1002/mabi.201300282
文献子类Article
英文摘要The recent advances in RNA interference (RNAi) technology provided novel and promising solutions for human cancer treatment. In this study, the application of dual pH-responsive cationic micellar nanoparticles for small interfering RNA (siRNA) and paclitaxel (PTX) co-delivery to overcome cancer multidrug resistance (MDR) is reported. The in vitro siRNA transfection shows that siRNA-luciferase (Luc) loaded micelleplexes efficiently silences Luc expression in various carcinoma cell lines. The Luc knockdown ability of the micelleplexes can be enhanced by choloquine (CQ) co-incubation. However, is abolished by bafilomycin-A1 (Baf-A1) treatment. The micelleplexes are further exploited for co-delivery of siRNA-Bcl-2 and PTX to Bcl-2 overexpressing A549 lung cancer cells (A549-Bcl-2). The experimental results show that the micelleplexes could sensitize A549-Bcl-2 cells to PTX via down-regulation of anti-apoptosis gene of Bcl-2, suggesting that PDMA-b-PDPA micelleplexes are promising nanovectors for siRNA and anti-cancer drug co-delivery to overcome cancer MDR.
WOS关键词TRIBLOCK COPOLYMERS ; GENE DELIVERY ; APOPTOSIS ; BCL-2 ; RNA ; DNA ; TRANSFECTION ; POLYPLEXES ; EXPRESSION ; DIBLOCK
资助项目National Basic Research Program of China[2013CB932704] ; National Basic Research Program of China[2010CB934000] ; National Basic Research Program of China[2012CB932502] ; National Natural Science Foundation of China[81230029] ; National Natural Science Foundation of China[81270047]
WOS研究方向Biochemistry & Molecular Biology ; Materials Science ; Polymer Science
语种英语
WOS记录号WOS:000330806100008
出版者WILEY-V C H VERLAG GMBH
源URL[http://119.78.100.183/handle/2S10ELR8/277316]  
专题药物制剂研究中心
通讯作者Li, Yaping
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China;
2.E China Normal Univ, Dept Chem, Shanghai 200241, Peoples R China;
3.Jiangsu Univ, Sch Pharm, Zhenjiang 202013, Peoples R China
推荐引用方式
GB/T 7714
Yu, Haijun,Xu, Zhiai,Chen, Xianzhi,et al. Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel[J]. MACROMOLECULAR BIOSCIENCE,2014,14(1):100-109.
APA Yu, Haijun.,Xu, Zhiai.,Chen, Xianzhi.,Xu, Leilei.,Yin, Qi.,...&Li, Yaping.(2014).Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel.MACROMOLECULAR BIOSCIENCE,14(1),100-109.
MLA Yu, Haijun,et al."Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel".MACROMOLECULAR BIOSCIENCE 14.1(2014):100-109.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。